Skip Nav Destination
Issues
Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity
Minttu Kansikas; Laura Vähätalo; Jukka Kantelinen; Mariann Kasela; Jaana Putula; Anni Døhlen; Pauliina Paloviita; Emmi Kärkkäinen; Niklas Lahti; Philippe Arnez; Sami Kilpinen; Beatriz Alcala-Repo; Kirsi Pylvänäinen; Minna Pöyhönen; Päivi Peltomäki; Heikki J. Järvinen; Toni T. Seppälä; Laura Renkonen-Sinisalo; Anna Lepistö; Jukka-Pekka Mecklin; Minna Nyström
Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men
Jason Garcia; Kirsten D. Krieger; Candice Loitz; Lillian M. Perez; Zachary A. Richards; Yves Helou; Steve Kregel; Sasha Celada; Clementina A. Mesaros; Maarten Bosland; Peter H. Gann; Thomas E. Willnow; Donald Vander Griend; Rick Kittles; Gail S. Prins; Trevor Penning; Larisa Nonn
Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Shaaron Ochoa-Rios; Calvin R.K. Blaschke; Mengjun Wang; Kendell D. Peterson; Andrew DelaCourt; Stéphane Elie Grauzam; David Lewin; Peggi Angel; Lewis R. Roberts; Richard Drake; Anand S. Mehta
Association Between Recreational Physical Activity and mTOR Signaling Pathway Protein Expression in Breast Tumor Tissue
Ting-Yuan David Cheng; Runzhi Zhang; Zhihong Gong; Bo Qin; Rikki A. Cannioto; Susmita Datta; Weizhou Zhang; Angela R. Omilian; Song Yao; Thaer Khoury; Chi-Chen Hong; Elisa V. Bandera; Christine B. Ambrosone
Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling
Israel Matos; Maunish Barvalia; Manreet K. Chehal; A. Gordon Robertson; Iva Kulic; Jessica A.F.D. Silva; Abhinandan Ranganathan; Amy Short; Yu-Hsuan Huang; Erin Long; John J. Priatel; Salim Dhanji; Brad H. Nelson; Danielle L. Krebs; Kenneth W. Harder
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
Cindy Lin; Laura Garcia-Gerique; Erin E. Bonner; Jerome Mastio; Matthew Rosenwasser; Zachary Cruz; Michael Lawler; Luca Bernabei; Kar Muthumani; Qin Liu; Mortimer Poncz; Thomas Vogl; Marie Törngren; Helena Eriksson; Dan T. Vogl; Dmitry I. Gabrilovich; Yulia Nefedova
Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
Josephine Kam Tai Dermawan; Khedoujia Nafa; Abhinita Mohanty; Yingjuan Xu; Ivelise Rijo; Jacklyn Casanova; Liliana Villafania; Jamal Benhamida; Ciara M. Kelly; William D. Tap; Patrick J. Boland; Nicola Fabbri; John H. Healey; Marc Ladanyi; Chao Lu; Meera Hameed
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non–small Cell Lung Cancer
Thazin N. Aung; Niki Gavrielatou; Ioannis A. Vathiotis; Aileen I. Fernandez; Saba Shafi; Vesal Yaghoobi; Sneha Burela; Tyler MacNeil; Fahad Shabbir Ahmed; Han Myint; Dallas B. Flies; Solomon Langermann; David L. Rimm
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin
Giulia Dellavedova; Alessandra Decio; Laura Formenti; Mark R. Albertella; Joanne Wilson; Anna D. Staniszewska; Elisabetta Leo; Raffaella Giavazzi; Carmen Ghilardi; Maria Rosa Bani
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy
Eihab Abdelfatah; Mark D. Long; Ryutaro Kajihara; Takaaki Oba; Takayoshi Yamauchi; Hongbin Chen; Joy Sarkar; Kristopher Attwood; Junko Matsuzaki; Brahm H. Segal; Grace K. Dy; Fumito Ito
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds